APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Glargine Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insulin Glargine Injection Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchInsulin Glargine Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Glargine Injection Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Insulin Glargine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Glargine Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Glargine Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Insulin Glargine Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Glargine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Glargine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Glargine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Glargine Injection include Tonghua Dongbao Pharmaceutical, Sanofi, Boao Bio Harmaceutical, Lilly, Gan & Lee and HEC Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Glargine Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Glargine Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Glargine Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Glargine Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Glargine Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Glargine Injection Market by Company

Tonghua Dongbao Pharmaceutical

Sanofi

Boao Bio Harmaceutical

Lilly

Gan & Lee

HEC Pharm

Insulin Glargine Injection Segment by Type

Pre-filled

Ordinary

Insulin Glargine Injection Segment by Application

Hospital

Clinic

Insulin Glargine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glargine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Glargine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glargine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Glargine Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Glargine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pre-filled Table 2. Major Company of Ordinary Table 3. Global Insulin Glargine Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 5. Global Insulin Glargine Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Insulin Glargine Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Insulin Glargine Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Insulin Glargine Injection Sales by Type (2027-2032) & (k units) Table 10. Global Insulin Glargine Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Insulin Glargine Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Insulin Glargine Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Insulin Glargine Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 15. North America Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Insulin Glargine Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Insulin Glargine Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Insulin Glargine Injection Industry Trends Table 25. Insulin Glargine Injection Industry Drivers Table 26. Insulin Glargine Injection Industry Opportunities and Challenges Table 27. Insulin Glargine Injection Industry Restraints Table 28. Global Insulin Glargine Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Insulin Glargine Injection Revenue Market Share by Company (2021-2026) Table 30. Global Insulin Glargine Injection Sales by Company (2021-2026) & (k units) Table 31. Global Insulin Glargine Injection Sales Share by Company (2021-2026) Table 32. Global Insulin Glargine Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Insulin Glargine Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Insulin Glargine Injection Major Company Production Sites and Headquarters Table 35. Global Insulin Glargine Injection Company, Product Type & Application Table 36. Global Insulin Glargine Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Insulin Glargine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Insulin Glargine Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Insulin Glargine Injection Sales by Region (2021-2026) & (k units) Table 41. Global Insulin Glargine Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Insulin Glargine Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Insulin Glargine Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Insulin Glargine Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Insulin Glargine Injection Sales by Region (2027-2032) & (k units) Table 46. Global Insulin Glargine Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Insulin Glargine Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Insulin Glargine Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Insulin Glargine Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Insulin Glargine Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 52. Global Insulin Glargine Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Insulin Glargine Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Insulin Glargine Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Insulin Glargine Injection Sales by Application (2027-2032) & (k units) Table 57. Global Insulin Glargine Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Insulin Glargine Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Insulin Glargine Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Insulin Glargine Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 62. North America Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Insulin Glargine Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Insulin Glargine Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Tonghua Dongbao Pharmaceutical Company Information Table 72. Tonghua Dongbao Pharmaceutical Business Overview Table 73. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product Portfolio Table 75. Tonghua Dongbao Pharmaceutical Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Insulin Glargine Injection Product Portfolio Table 80. Sanofi Recent Development Table 81. Boao Bio Harmaceutical Company Information Table 82. Boao Bio Harmaceutical Business Overview Table 83. Boao Bio Harmaceutical Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Boao Bio Harmaceutical Insulin Glargine Injection Product Portfolio Table 85. Boao Bio Harmaceutical Recent Development Table 86. Lilly Company Information Table 87. Lilly Business Overview Table 88. Lilly Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Lilly Insulin Glargine Injection Product Portfolio Table 90. Lilly Recent Development Table 91. Gan & Lee Company Information Table 92. Gan & Lee Business Overview Table 93. Gan & Lee Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Gan & Lee Insulin Glargine Injection Product Portfolio Table 95. Gan & Lee Recent Development Table 96. HEC Pharm Company Information Table 97. HEC Pharm Business Overview Table 98. HEC Pharm Insulin Glargine Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. HEC Pharm Insulin Glargine Injection Product Portfolio Table 100. HEC Pharm Recent Development Table 101. North America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Insulin Glargine Injection Sales by Country (2021-2026) & (k units) Table 103. North America Insulin Glargine Injection Sales Market Share by Country (2021-2026) Table 104. North America Insulin Glargine Injection Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Insulin Glargine Injection Sales Market Share Forecast by Country (2027-2032) Table 106. North America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Insulin Glargine Injection Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Insulin Glargine Injection Market Share by Country (2021-2026) Table 109. North America Insulin Glargine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Insulin Glargine Injection Market Share Forecast by Country (2027-2032) Table 111. Europe Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Insulin Glargine Injection Sales by Country (2021-2026) & (k units) Table 113. Europe Insulin Glargine Injection Sales Market Share by Country (2021-2026) Table 114. Europe Insulin Glargine Injection Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Insulin Glargine Injection Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Insulin Glargine Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Insulin Glargine Injection Market Share by Country (2021-2026) Table 119. Europe Insulin Glargine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Insulin Glargine Injection Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Insulin Glargine Injection Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Insulin Glargine Injection Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Insulin Glargine Injection Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Insulin Glargine Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Insulin Glargine Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Insulin Glargine Injection Market Share by Country (2021-2026) Table 129. Asia-Pacific Insulin Glargine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Insulin Glargine Injection Market Share Forecast by Country (2027-2032) Table 131. Latin America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Insulin Glargine Injection Sales by Country (2021-2026) & (k units) Table 133. Latin America Insulin Glargine Injection Sales Market Share by Country (2021-2026) Table 134. Latin America Insulin Glargine Injection Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Insulin Glargine Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Insulin Glargine Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Insulin Glargine Injection Market Share by Country (2021-2026) Table 139. Latin America Insulin Glargine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Insulin Glargine Injection Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Insulin Glargine Injection Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Insulin Glargine Injection Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Insulin Glargine Injection Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Insulin Glargine Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Insulin Glargine Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Insulin Glargine Injection Market Share by Country (2021-2026) Table 149. Middle East and Africa Insulin Glargine Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Insulin Glargine Injection Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Insulin Glargine Injection Distributors List Table 154. Insulin Glargine Injection Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Insulin Glargine Injection Image Figure 2. Global Insulin Glargine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Glargine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Glargine Injection Sales (2021-2032) & (k units) Figure 5. Pre-filled Image Figure 6. Global Pre-filled Sales YoY Growth (2021-2032) & (k units) Figure 7. Ordinary Image Figure 8. Global Ordinary Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Insulin Glargine Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Insulin Glargine Injection Market Share by Type 2025 VS 2032 Figure 11. North America Insulin Glargine Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Insulin Glargine Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Insulin Glargine Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Insulin Glargine Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Insulin Glargine Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Insulin Glargine Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Insulin Glargine Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Insulin Glargine Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Insulin Glargine Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Insulin Glargine Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Insulin Glargine Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Insulin Glargine Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Insulin Glargine Injection Market Share by Application 2025 VS 2032 Figure 29. North America Insulin Glargine Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Insulin Glargine Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Insulin Glargine Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Insulin Glargine Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Insulin Glargine Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Insulin Glargine Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Insulin Glargine Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Insulin Glargine Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Insulin Glargine Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Insulin Glargine Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Insulin Glargine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Insulin Glargine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Insulin Glargine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Insulin Glargine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Insulin Glargine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Insulin Glargine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Insulin Glargine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Insulin Glargine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Insulin Glargine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Insulin Glargine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Insulin Glargine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Insulin Glargine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Insulin Glargine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Insulin Glargine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Insulin Glargine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Insulin Glargine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Insulin Glargine Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Insulin Glargine Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Insulin Glargine Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Insulin Glargine Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Insulin Glargine Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Insulin Glargine Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-filled
  • Ordinary
Applications
  • Hospital
  • Clinic
Companies covered
  • Tonghua Dongbao Pharmaceutical
  • Sanofi
  • Boao Bio Harmaceutical
  • Lilly
  • Gan & Lee
  • HEC Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Glargine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Glargine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Glargine Injection Market by Type
  6. 1.3.1 Pre-filled
  7. 1.3.2 Ordinary
  8. 1.4 Global Insulin Glargine Injection Market Size by Type
  9. 1.4.1 Global Insulin Glargine Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Insulin Glargine Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Insulin Glargine Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Insulin Glargine Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Insulin Glargine Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Insulin Glargine Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Insulin Glargine Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Insulin Glargine Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Glargine Injection Industry Trends
  2. 2.2 Insulin Glargine Injection Industry Drivers
  3. 2.3 Insulin Glargine Injection Industry Opportunities and Challenges
  4. 2.4 Insulin Glargine Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Glargine Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Glargine Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Glargine Injection Price (2021-2026)
  4. 3.4 Global Insulin Glargine Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Glargine Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Glargine Injection Company, Product Type & Application
  7. 3.7 Global Insulin Glargine Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Glargine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Glargine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Glargine Injection Tier 1, Tier 2, and Tier 3
4 Insulin Glargine Injection Regional Status and Outlook
  1. 4.1 Global Insulin Glargine Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Glargine Injection Historic Market Size by Region
  3. 4.2.1 Global Insulin Glargine Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Glargine Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Glargine Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Glargine Injection Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Glargine Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Glargine Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Glargine Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Glargine Injection by Application
  1. 5.1 Insulin Glargine Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Insulin Glargine Injection Market Size by Application
  5. 5.2.1 Global Insulin Glargine Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Insulin Glargine Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Insulin Glargine Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Insulin Glargine Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Insulin Glargine Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Insulin Glargine Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Insulin Glargine Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Insulin Glargine Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tonghua Dongbao Pharmaceutical
  2. 6.1.1 Tonghua Dongbao Pharmaceutical Company Information
  3. 6.1.2 Tonghua Dongbao Pharmaceutical Business Overview
  4. 6.1.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product Portfolio
  6. 6.1.5 Tonghua Dongbao Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Insulin Glargine Injection Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Boao Bio Harmaceutical
  14. 6.3.1 Boao Bio Harmaceutical Company Information
  15. 6.3.2 Boao Bio Harmaceutical Business Overview
  16. 6.3.3 Boao Bio Harmaceutical Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boao Bio Harmaceutical Insulin Glargine Injection Product Portfolio
  18. 6.3.5 Boao Bio Harmaceutical Recent Developments
  19. 6.4 Lilly
  20. 6.4.1 Lilly Company Information
  21. 6.4.2 Lilly Business Overview
  22. 6.4.3 Lilly Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lilly Insulin Glargine Injection Product Portfolio
  24. 6.4.5 Lilly Recent Developments
  25. 6.5 Gan & Lee
  26. 6.5.1 Gan & Lee Company Information
  27. 6.5.2 Gan & Lee Business Overview
  28. 6.5.3 Gan & Lee Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gan & Lee Insulin Glargine Injection Product Portfolio
  30. 6.5.5 Gan & Lee Recent Developments
  31. 6.6 HEC Pharm
  32. 6.6.1 HEC Pharm Company Information
  33. 6.6.2 HEC Pharm Business Overview
  34. 6.6.3 HEC Pharm Insulin Glargine Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HEC Pharm Insulin Glargine Injection Product Portfolio
  36. 6.6.5 HEC Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Glargine Injection Sales by Country
  2. 7.1.1 North America Insulin Glargine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Glargine Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Glargine Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Glargine Injection Market Size by Country
  6. 7.2.1 North America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Glargine Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Glargine Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Glargine Injection Sales by Country
  2. 8.1.1 Europe Insulin Glargine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Glargine Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Glargine Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Glargine Injection Market Size by Country
  6. 8.2.1 Europe Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Glargine Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Glargine Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Glargine Injection Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Glargine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Glargine Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Glargine Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Glargine Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Glargine Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Glargine Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Glargine Injection Sales by Country
  2. 10.1.1 South America Insulin Glargine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Glargine Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Glargine Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Glargine Injection Market Size by Country
  6. 10.2.1 South America Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Glargine Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Glargine Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Glargine Injection Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Glargine Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Glargine Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Glargine Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Glargine Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Glargine Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Glargine Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Glargine Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Glargine Injection Value Chain Analysis
  2. 12.1.1 Insulin Glargine Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Glargine Injection Production Mode & Process
  7. 12.2 Insulin Glargine Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Glargine Injection Distributors
  10. 12.2.3 Insulin Glargine Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst